Quick answer

Nuclear medicine is a branch of medical imaging and treatment that uses small amounts of radioactive material, called radiopharmaceuticals, to diagnose and treat disease at the molecular level. These substances are administered to patients and tracked using specialized cameras like PET and SPECT scanners, or used directly as targeted treatment. Because most radiopharmaceuticals decay within hours, and are classified as Class 7 dangerous goods, their transportation requires trained couriers, strict regulatory compliance, and delivery windows built around each isotope’s decay clock rather than standard shipping timelines.

For hospitals, imaging centres, and nuclear medicine facilities, understanding both the science behind nuclear medicine and the logistics required to support it is essential. A single delayed shipment does not just mean a late delivery. It can mean a radiopharmaceutical decaying below a usable dose before it ever reaches the patient.

Introduction to Nuclear Medicine

Nuclear medicine is a medical specialty that uses trace amounts of radioactive materials to diagnose and treat conditions ranging from cancer to heart disease to neurological disorders. Unlike imaging techniques such as X-ray or MRI, which primarily capture the structure of the body, nuclear medicine captures function, showing how organs and tissues are actually behaving at a cellular level. This makes it possible to detect disease processes before they become visible through anatomical changes alone.

How Does Nuclear Medicine Work?

At the core of nuclear medicine is the radiopharmaceutical, sometimes called a radiotracer or radionuclide. This is a compound that combines a radioactive isotope with a carrier molecule designed to travel to a specific organ, tissue, or biological process in the body. Once administered, typically by injection, ingestion, or inhalation, the radiopharmaceutical accumulates in the target area and emits gamma rays or positrons as it decays. Specialized cameras detect this emission and translate it into detailed images of how that organ or tissue is functioning.

The radioactive isotope used depends entirely on the clinical purpose. Some isotopes have very short half-lives, meaning they lose half their radioactivity within a matter of hours, which limits patient radiation exposure but also means these products must be used quickly after production.

What Is Nuclear Medicine Used For? Diagnostic Imaging Techniques

Nuclear medicine supports two major categories of imaging.

Positron Emission Tomography (PET) 

Uses radiotracers that emit positrons, most commonly fluorodeoxyglucose (FDG), to map metabolic activity in the body. Because cancer cells often metabolize glucose at a higher rate than healthy tissue, PET imaging is widely used in oncology to detect tumours, stage cancer, and monitor how a patient is responding to treatment. PET is also used in neurology to study conditions like Alzheimer’s disease and epilepsy, and in cardiology to assess blood flow to the heart.

Single Photon Emission Computed Tomography (SPECT) 

Uses gamma-emitting isotopes, such as technetium-99m, to produce three-dimensional images of organ function. SPECT is commonly used to evaluate blood flow to the heart, assess bone conditions, and investigate kidney or thyroid function.

Beyond diagnostics, nuclear medicine also plays a direct role in treatment. Targeted radiotherapy uses radiopharmaceuticals to deliver radiation directly to diseased cells, such as radioactive iodine for certain thyroid conditions, while sparing surrounding healthy tissue far more precisely than external radiation alone.

Radiopharmaceuticals and the Challenge of Radioactive Decay

What makes radiopharmaceutical logistics fundamentally different from standard medical courier work is decay. Fluorine-18, used in FDG-PET imaging, has a half-life of roughly 110 minutes, meaning its radioactivity drops by half in under two hours. Technetium-99m, one of the most widely used isotopes in SPECT imaging, has a half-life of about six hours. In both cases, every hour a shipment spends in transit is an hour of clinically usable material lost.

This is why radiopharmaceutical transport cannot be planned like a typical delivery. Routes, pickup windows, and delivery times all have to be built backward from the moment a dose needs to reach a patient, with as little ground time and handling delay as possible. A shipment that would be considered on schedule for almost any other medical product can arrive functionally useless if it is delayed even by an hour or two.

Regulation and Safety Guidelines for Radiopharmaceutical Transport

Because radiopharmaceuticals are radioactive, their transportation falls under Class 7 dangerous goods regulations. In Canada, this means compliance with the Transportation of Dangerous Goods (TDG) Regulations, overseen in coordination with the Canadian Nuclear Safety Commission. Nearly a million shipments of nuclear substances move to, from, and within Canada each year, underscoring just how routine, and how tightly regulated, this kind of transport actually is.

Carriers handling Class 7 materials are required to maintain a radiation protection program, use standardized signage and shipping documentation, and ensure every employee involved has completed TDG training specific to radioactive material handling. That training covers safe handling procedures, documentation requirements, and Emergency Response Assistance Plan protocols in case of an incident during transport. Certification is not a one-time requirement either. TDG training credentials expire after 36 months, meaning couriers must be recertified on a recurring basis to stay compliant as regulations evolve. Understanding medical courier compliance more broadly helps illustrate just how much structure sits behind what looks, on the surface, like a simple delivery.

Advancements and Research in Nuclear Medicine

Nuclear medicine continues to evolve quickly, particularly in the growing field of theranostics, which pairs a diagnostic radiopharmaceutical with a therapeutic one targeting the same biological marker. This approach allows clinicians to confirm that a tumour expresses a specific target before delivering a matched radioligand therapy directly to it, improving precision in cancer treatment. As these targeted therapies expand, so does the demand for reliable, time-critical logistics capable of supporting increasingly personalized, patient-specific radiopharmaceutical doses rather than large batch shipments.

Expertise in Nuclear Medicine Logistics

Supporting nuclear medicine means building logistics around the realities of radioactive decay, not around standard delivery expectations. That includes radiopharmaceutical transportation handled by drivers who have completed TDG training and certification specific to Class 7 materials, alongside secure, documented handling procedures at every step of the chain of custody.

Temperature control matters here too, since many radiopharmaceuticals and related biological products require consistent conditions throughout transport. Cold chain and temperature-controlled transport capabilities ensure products stay within required ranges from pickup to delivery, an integrated part of the broader supply chain rather than a separate add-on service.

Reliable coordination matters just as much as the transport itself. Hospitals, imaging centres, and nuclear medicine facilities depend on couriers who understand the clinical stakes of a delayed shipment and can communicate proactively when timing is tight. Healthcare-trained couriers bring that understanding to every pickup and delivery, treating each shipment with the urgency its decay clock actually demands. Beyond radiopharmaceuticals specifically, understanding the full range of types of medical delivery and the medical delivery safety factors that apply across the industry helps explain why specialized courier partnerships matter so much in modern healthcare logistics.

Frequently Asked Questions

What is nuclear medicine used for? 

Nuclear medicine is used to diagnose and monitor conditions like cancer, heart disease, and neurological disorders through imaging techniques such as PET and SPECT, and to deliver targeted radiation treatment directly to diseased tissue.

How does nuclear medicine differ from other imaging like X-ray or MRI? 

Nuclear medicine shows how organs and tissues function at a cellular level, while X-ray and MRI primarily show structure. This allows nuclear medicine to detect disease processes earlier than anatomical imaging alone.

Why is radiopharmaceutical transport so time-sensitive? 

Most radiopharmaceuticals have short half-lives, ranging from under two hours to about six hours for common isotopes, meaning their radioactivity, and clinical usefulness, decreases rapidly during transit.

What regulations apply to transporting radiopharmaceuticals in Canada?

Radiopharmaceuticals are classified as Class 7 dangerous goods and must be transported in compliance with Transportation of Dangerous Goods (TDG) Regulations, with drivers holding current TDG certification specific to radioactive materials.

What should a hospital or imaging centre look for in a radiopharmaceutical courier? 

Look for TDG-certified drivers, documented chain of custody procedures, temperature-controlled capability where needed, and a track record of coordinating time-critical deliveries with healthcare facilities specifically.